Gualou Xiebai Decoction, a Traditional Chinese Medicine, Prevents Cardiac Reperfusion Injury of Hyperlipidemia Rat via Energy Modulation
Open Access
- 4 April 2018
- journal article
- research article
- Published by Frontiers Media SA in Frontiers in Physiology
- Vol. 9, 296
Abstract
Background: Gualou Xiebai Decoction (GLXB) is a classic prescription of Chinese medicine used for the treatment of cardiac problems. The present study was designed to explore the effect and mechanism of GLXB on ischemia/reperfusion (I/R) induced disorders in myocardial structure and function, focusing on the regulation of energy metabolism and the RhoA/ROCK pathway. Methods: After hyperlipidemic rat model was established by oral administration of high fat diet, the rats were treated with GLXB for 6 weeks and subjected to 30 min occlusion of the left anterior descending coronary artery (LADCA) followed by 90 min reperfusion to elicit I/R challenge. Myocardial infarct size was assessed by Evans blue-TTC staining. Myocardial blood flow (MBF) and cardiac function were evaluated. Enzyme-linked immunosorbent assay was performed to examine the content of ATP, ADP, AMP, CK, CK-MB, LDH, cTnT, cTnI, and IL-6. Double staining of F-actin and terminal deoxynucleotidyl transferase-mediated dUTP nick end labeling was conducted to assess myocardial apoptosis. Expressions of ATP synthase subunit δ (ATP 5D), and RhoA and ROCK were determined by Western blotting. Results: Administration with GLXB at high dose for 6 weeks protected heart against I/R-induced MBF decrease, myocardial infarction and apoptosis, ameliorated I/R-caused impairment of cardiac function and myocardial structure, restored the decrease in the ratio of ADP/ATP and AMP/ATP, and the expression of ATP 5D with inhibiting the expression of RhoA and ROCK. Conclusions: Treatment with GLXB effectively protects myocardial structure and function from I/R challenge, possibly via regulating energy metabolism involving inactivation of RhoA/ROCK signaling pathway.Keywords
This publication has 43 references indexed in Scilit:
- Mitochondria as a Therapeutic Target in Heart FailureJACC, 2013
- Aged garlic extract enhances exercise-mediated improvement of metabolic parameters in high fat diet-induced obese ratsNutrition Research and Practice, 2012
- Effect of the Rho kinase inhibitor Y‐27632 on the proteome of hearts with ischemia–reperfusion injuryProteomics, 2010
- Increased Myocardial Susceptibility to Repetitive Ischemia With High‐fat diet‐induced ObesitObesity, 2008
- Administration of the Rho-Kinase Inhibitor Fasudil Before Ischemia or just After Reperfusion, but not 30 min After Reperfusion, Protects the Stunned Myocardium in SwineCardiovascular Drugs and Therapy, 2008
- Hypercholesterolemia increases myocardial oxidative and nitrosative stress thereby leading to cardiac dysfunction in apoB-100 transgenic miceCardiovascular Research, 2007
- Myocardial Reperfusion InjuryNew England Journal of Medicine, 2007
- Rho kinase activation plays a major role as a mediator of irreversible injury in reperfused myocardiumAmerican Journal of Physiology-Heart and Circulatory Physiology, 2007
- Hyperlipidemia Attenuates the Infarct Size-Limiting Effect of Ischemic Preconditioning: Role of Matrix Metalloproteinase-2 InhibitionThe Journal of Pharmacology and Experimental Therapeutics, 2006
- Myocardial ischaemia/reperfusion injury and preconditioning: effects of hypercholesterolaemia/hyperlipidaemiaBritish Journal of Pharmacology, 2003